rs1050152 — SLC22A4 OCTN1 L503F

OCTN1 L503F — When a Transporter Variant Reshapes the IBD5 Risk Haplotype

OCTN1¹¹ OCTN1
Organic Cation Transporter Novel 1 — a membrane transport protein expressed in the intestine, kidney, liver, lung, and immune cells that shuttles organic cations and the dietary antioxidant ergothioneine into cells is the product of the SLC22A4 gene on chromosome 5q31. The region around SLC22A4 is one of the earliest and most replicated inflammatory bowel disease susceptibility loci in human genetics — a 250 kb haplotype block called the IBD5 locus²² IBD5 locus
A linkage-disequilibrium block on chromosome 5q31 first identified in a Canadian sib-pair study of Crohn's disease; the locus spans SLC22A4, SLC22A5, and several immune-regulatory genes including IRF1 and IL5. The L503F missense variant in OCTN1 is one of two functional variants proposed to underlie the IBD5 risk haplotype, the other being rs2631367 (-207G>C) in the SLC22A5 (OCTN2) promoter.

The Mechanism

OCTN1 uses a sodium gradient to transport ergothioneine³³ ergothioneine
A naturally occurring amino acid synthesized only by fungi and some bacteria; humans obtain it entirely from diet, primarily through mushrooms, oats, and black beans; OCTN1 is the dedicated mammalian ergothioneine transporter into cells. The L503F substitution — a leucine-to-phenylalanine swap in the 11th transmembrane domain — meaningfully alters the transporter's kinetic profile.

Gründemann et al. showed⁴⁴ Gründemann et al. showed
PNAS 2009 — the 503F variant has 3-fold higher substrate affinity (lower Km) and 2-fold lower maximal transport velocity (Vmax) for ergothioneine, yielding 50% higher net transport efficiency at the physiological ergothioneine concentrations found in food and portal blood. The result: 503F carriers (CT and TT) accumulate higher ergothioneine concentrations in OCTN1-expressing tissues — including intestinal epithelium, macrophages, and neutrophils — than 503L homozygotes (CC) eating the same diet. In parallel, the 503F variant shows reduced carnitine transport (2.7-fold lower uptake) and altered uptake of various organic cations.

The functional paradox is that 503F is an ergothioneine gain-of-function variant associated with increased inflammatory disease risk. Current evidence suggests the primary causal signal at IBD5 may reside in nearby variants near IRF1 (Interferon Regulatory Factor 1)⁵⁵ Current evidence suggests the primary causal signal at IBD5 may reside in nearby variants near IRF1 (Interferon Regulatory Factor 1)
Festen et al., Nature Genetics 2011 — reanalysis of IBD5 suggested that 503F may be a recent European-enriched adaptation that swept to high frequency in linkage disequilibrium with the true causal signal, rather than being causal itself. Regardless of causality, the T allele remains a reliable risk tag for the IBD5 haplotype.

The Evidence

Peltekova et al.⁶⁶ Peltekova et al.
Nature Genetics 2004 — first proposed the two-locus IBD5 TC haplotype (SLC22A4 L503F-T + SLC22A5 -207C) as functional Crohn's disease risk variants; TC heterozygotes showed OR 2.1–2.56; TC/TC homozygotes showed OR 3.43–5.14 in two independent Canadian cohorts. This seminal finding made the IBD5 TC haplotype one of the best-replicated Crohn's disease susceptibility signals in the pre-GWAS era.

Subsequent replication studies confirmed the association in European cohorts. Noble et al., Gastroenterology 2005⁷⁷ Noble et al., Gastroenterology 2005
Studied TC haplotype in 1,400 Crohn's disease patients and 725 controls; TC/TC homozygotes were more likely to require intestinal resection and had higher rates of stricturing or penetrating disease, establishing a genotype-severity relationship beyond susceptibility alone.

Population data are striking: the T allele reaches 42% in European-Americans but drops to approximately 2% in East Asians, consistent with the observation that the IBD5 association with Crohn's disease is not observed in Japanese populations. This European enrichment has been proposed to reflect a recent selective sweep in European ancestry, possibly related to dietary adaptation to mushroom-rich environments.

Practical Actions

For TT homozygotes — carrying two copies of the 503F allele — the OCTN1 transporter accumulates particularly high ergothioneine tissue concentrations. The clinical significance is primarily as a tag for the IBD5 risk haplotype: elevated Crohn's disease susceptibility, with evidence that disease course may be more severe. Monitoring for early gastrointestinal symptoms and optimizing the gut microbiome through diet are the most actionable responses.

Because OCTN1 also regulates carnitine transport (with 503F reducing carnitine uptake 2.7-fold in vitro), TT homozygotes may have modestly reduced intestinal carnitine absorption. Carnitine status can be supported through dietary sources (red meat, dairy) or supplementation.

Interactions

The T allele at rs1050152 is the primary coding component of the IBD5 TC haplotype. Its partner variant, rs2631367 (-207G>C in the SLC22A5/OCTN2 promoter), reduces OCTN2 expression and synergizes with L503F to confer full TC haplotype risk for Crohn's disease. TC/TC homozygotes — those carrying the T allele here AND the C allele at rs2631367 — show the highest disease risk (OR 3.43–5.14) in the original Peltekova data. Single-locus carriage at either site confers intermediate risk.

Downstream of IBD5, NOD2/CARD15 variants (rs2066844, rs2066845, rs2066847) act in a common pathogenic pathway with the OCTN haplotype; compound carriage of IBD5 TC haplotype plus NOD2 variants may substantially further elevate Crohn's disease risk.